Susquehanna International Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,796
| Closed | -$111K | – | 7433 |
|
|
2025
Q1 | $111K | Buy |
13,796
+10,153
| +279% | +$81.5K | ﹤0.01% | 5824 |
|
|
2024
Q4 | $35.2K | Buy |
3,643
+2,460
| +208% | +$23.8K | ﹤0.01% | 5932 |
|
|
2024
Q3 | $22K | Sell |
1,183
-6,126
| -84% | -$114K | ﹤0.01% | 5398 |
|
|
2024
Q2 | $122K | Buy |
7,309
+3,322
| +83% | +$55.3K | ﹤0.01% | 5021 |
|
|
2024
Q1 | $69.2K | Buy |
3,987
+2,426
| +155% | +$42.1K | ﹤0.01% | 5107 |
|
|
2023
Q4 | $24.4K | Sell |
1,561
-4,384
| -74% | -$68.5K | ﹤0.01% | 5652 |
|
|
2023
Q3 | $294K | Buy |
5,945
+4,912
| +476% | +$243K | ﹤0.01% | 4062 |
|
|
2023
Q2 | $80.8K | Buy |
1,033
+308
| +42% | +$24.1K | ﹤0.01% | 5085 |
|
|
2023
Q1 | $65.7K | Buy |
+725
| New | +$65.7K | ﹤0.01% | 5375 |
|
|
2022
Q4 | – | Sell |
-1,449
| Closed | -$263K | – | 6905 |
|
|
2022
Q3 | $263K | Buy |
1,449
+432
| +42% | +$78.4K | ﹤0.01% | 4402 |
|
|
2022
Q2 | $91K | Sell |
1,017
-85
| -8% | -$7.61K | ﹤0.01% | 5036 |
|
|
2022
Q1 | $171K | Sell |
1,102
-93
| -8% | -$14.4K | ﹤0.01% | 4919 |
|
|
2021
Q4 | $356K | Buy |
1,195
+314
| +36% | +$93.5K | ﹤0.01% | 4281 |
|
|
2021
Q3 | $508K | Sell |
881
-414
| -32% | -$239K | ﹤0.01% | 3684 |
|
|
2021
Q2 | $588K | Sell |
1,295
-1,815
| -58% | -$824K | ﹤0.01% | 3693 |
|
|
2021
Q1 | $1.67M | Buy |
3,110
+2,554
| +459% | +$1.37M | ﹤0.01% | 2325 |
|
|
2020
Q4 | $491K | Buy |
+556
| New | +$491K | ﹤0.01% | 3431 |
|